D-Index & Metrics Best Publications
Medicine
Poland
2022

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 105 Citations 53,520 554 World Ranking 2957 National Ranking 2

Research.com Recognitions

Awards & Achievements

2022 - Research.com Medicine in Poland Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

Jan Lubinski spends much of his time researching Breast cancer, Internal medicine, Oncology, Genome-wide association study and Genetics. Breast cancer is a subfield of Cancer that Jan Lubinski studies. His Cancer research focuses on subjects like Endocrinology, which are linked to Gene mutation.

Jan Lubinski has researched Oncology in several fields, including Germline mutation, BRCA mutation, Ovarian cancer, Chemotherapy and Relative risk. His Genome-wide association study research is multidisciplinary, incorporating elements of Case-control study, Genetic association, Locus and Bioinformatics. His Allele study integrates concerns from other disciplines, such as Molecular biology and Disease.

His most cited work include:

  • Biological insights from 108 schizophrenia-associated genetic loci (4834 citations)
  • Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies (2742 citations)
  • Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk (951 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Internal medicine, Breast cancer, Oncology, Cancer and Genetics. His work deals with themes such as Germline mutation and Genotype, which intersect with Internal medicine. His Breast cancer research is multidisciplinary, incorporating perspectives in CHEK2, Cancer research, Gynecology and Case-control study.

His Oncology study incorporates themes from Genetic predisposition, Hazard ratio, Prostate cancer, Family history and Risk factor. His biological study spans a wide range of topics, including Gastroenterology, Lung cancer, Pathology and Immunology. His study in Genome-wide association study is interdisciplinary in nature, drawing from both Genetic association and Bioinformatics.

He most often published in these fields:

  • Internal medicine (50.54%)
  • Breast cancer (42.99%)
  • Oncology (41.51%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (50.54%)
  • Oncology (41.51%)
  • Breast cancer (42.99%)

In recent papers he was focusing on the following fields of study:

Jan Lubinski mostly deals with Internal medicine, Oncology, Breast cancer, Cancer and Odds ratio. Jan Lubinski focuses mostly in the field of Internal medicine, narrowing it down to matters related to Gastroenterology and, in some cases, Lung cancer. His work deals with themes such as Germline mutation, PALB2, Ovarian cancer, Allele and Prostate cancer, which intersect with Oncology.

His Breast cancer research incorporates themes from Genome-wide association study, Family history and Mutation. The various areas that Jan Lubinski examines in his Genome-wide association study study include Genetic association and Medical genetics. His Cancer research integrates issues from Gene and Germline.

Between 2017 and 2021, his most popular works were:

  • Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes (328 citations)
  • Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (268 citations)
  • Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (257 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

Internal medicine, Breast cancer, Oncology, Cancer and Genome-wide association study are his primary areas of study. His research investigates the connection with Breast cancer and areas like Genetic testing which intersect with concerns in CHEK2, PALB2, Mutation and Genotyping. His Oncology research includes elements of Serous fluid, Ovarian tumor, Ovarian cancer and Prostate cancer.

His Ovarian cancer study combines topics in areas such as Oophorectomy, Tobacco smoke and Population study. His Genome-wide association study research incorporates elements of Disease, Genetic association, Bioinformatics and Medical genetics. Jan Lubinski has included themes like Genetic model and Expression quantitative trait loci in his Genetic association study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Biological insights from 108 schizophrenia-associated genetic loci

Stephan Ripke;Stephan Ripke;Benjamin M. Neale;Benjamin M. Neale;Aiden Corvin;James T. R. Walters.
Nature (2014)

4139 Citations

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies

A Antoniou;Pdp Pharoah;S Narod;HA Risch.
American Journal of Human Genetics (2003)

4089 Citations

HNPCC (Lynch Syndrome): Differential Diagnosis, Molecular Genetics and Management - a Review

Henry T Lynch;Jane F Lynch;Trudy G Shaw;Jan Lubiński.
Hereditary Cancer in Clinical Practice (2003)

2826 Citations

Large-scale genotyping identifies 41 new loci associated with breast cancer risk

Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini.
Nature Genetics (2013)

1074 Citations

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

John Burn;Anne Marie Gerdes;Finlay MacRae;Jukka Pekka Mecklin.
The Lancet (2011)

966 Citations

Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores

Bjarni J. Vilhjálmsson;Jian Yang;Hilary K. Finucane;Alexander Gusev.
American Journal of Human Genetics (2015)

960 Citations

Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

Ganna Chornokur;Hui-Yi Lin;Jonathan P. Tyrer;Kate Lawrenson.
PLOS ONE (2015)

951 Citations

Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval

Peter C. Fong;Timothy A. Yap;David S. Boss;Craig P. Carden.
Journal of Clinical Oncology (2010)

926 Citations

Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies

Xiaohong R. Yang;Jenny Chang-Claude;Ellen L. Goode;Fergus J. Couch.
Journal of the National Cancer Institute (2011)

781 Citations

Salpingo-oophorectomy and the Risk of Ovarian, Fallopian Tube, and Peritoneal Cancers in Women With a BRCA1 or BRCA2 Mutation

Amy Finch;Mario Beiner;Jan Lubinski;Henry T. Lynch.
JAMA (2006)

696 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jan Lubinski

Graham G. Giles

Graham G. Giles

University of Melbourne

Publications: 363

Douglas F. Easton

Douglas F. Easton

University of Cambridge

Publications: 262

John L. Hopper

John L. Hopper

University of Melbourne

Publications: 258

Ole A. Andreassen

Ole A. Andreassen

Oslo University Hospital

Publications: 258

Steven A. Narod

Steven A. Narod

University of Toronto

Publications: 241

Roger L. Milne

Roger L. Milne

Cancer Council Victoria

Publications: 233

Melissa C. Southey

Melissa C. Southey

Cancer Council Victoria

Publications: 228

Paul D.P. Pharoah

Paul D.P. Pharoah

University of Cambridge

Publications: 202

Esther M. John

Esther M. John

Stanford University

Publications: 193

Thomas Werge

Thomas Werge

University of Copenhagen

Publications: 189

Jenny Chang-Claude

Jenny Chang-Claude

German Cancer Research Center

Publications: 184

Rosalind A. Eeles

Rosalind A. Eeles

Institute of Cancer Research

Publications: 180

Stephen J. Chanock

Stephen J. Chanock

National Institutes of Health

Publications: 177

Fergus J. Couch

Fergus J. Couch

Mayo Clinic

Publications: 169

Patrick F. Sullivan

Patrick F. Sullivan

University of North Carolina at Chapel Hill

Publications: 168

Anders D. Børglum

Anders D. Børglum

Lundbeck (Denmark)

Publications: 167

Trending Scientists

Iain M. Suthers

Iain M. Suthers

University of New South Wales

Sarah A. Woodin

Sarah A. Woodin

University of South Carolina

Corine Bertolotto

Corine Bertolotto

Inserm : Institut national de la santé et de la recherche médicale

Richard A. Lang

Richard A. Lang

Cincinnati Children's Hospital Medical Center

Tutis Vilis

Tutis Vilis

University of Western Ontario

Dong Zhou

Dong Zhou

Sichuan University

Donna M. Lloyd

Donna M. Lloyd

University of Leeds

Peter Vogel

Peter Vogel

St. Jude Children's Research Hospital

Karlene Ball

Karlene Ball

University of Alabama at Birmingham

Mark R. Shinn

Mark R. Shinn

University of Oregon

Linda Van Horn

Linda Van Horn

Northwestern University

Jane Green

Jane Green

University of Oxford

Rebecca A. Betensky

Rebecca A. Betensky

New York University

Robert E. Tarone

Robert E. Tarone

Vanderbilt University Medical Center

Sean G. Ryan

Sean G. Ryan

University of Hertfordshire

Something went wrong. Please try again later.